v3.26.1
Schedule of Equity and Non-Controlling Interests (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Non-controlling net loss $ (9,317) $ (8,248) $ (16,052) $ (14,835)
Net loss non-controlling interest (2) (2) (3) (17)
Prior period balance     (111)  
Ending period balance (114)   (114)  
Exozyme Technologies Inc [Member]        
Non-controlling net loss     $ (9) $ (51)
Weighted average non-controlling percentage     32.13% 32.18%
Net loss non-controlling interest     $ (3) $ (17)
Prior period balance     (111) (90)
Stock-based compensation    
Ending period balance $ (114) $ (107) $ (114) $ (107)